Skip to main content

Advertisement

SpringerLink
Log in

Comparison of Efficacy of Pharmacologic Treatments in Pregnancy- and Lactation-Associated Osteoporosis

  • Treating Bone Loss in Challenging Situations
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Pregnancy- and lactation-associated osteoporosis (PLO) is a rare disorder characterised by the occurrence of multiple fragility fractures, particularly at vertebral columns, in the third trimester or early postpartum period. Whether implementation for pharmacologic treatments in patients with PLO remains controversial partly due to rarity of data and known indolent recovery of bone mass after fracture, various pharmacologic treatments have been reported to effectively facilitate bone mineral density (BMD) increase in anecdotal case reports or cohorts based on individualised clinical assessment of subsequent fracture risk. In this study, we aimed to summarise pharmacologic strategies and its efficacy on BMD change and subsequent fractures using individual case data or frequency-weighted group data from available literatures. Among 2438 studies identified using PubMed and Embase until Jan 2019, 30 studies which reported pharmacologic treatment (23 studies) or observation (7 studies) were included. Reported treatment options consisted of observation with calcium/vitamin D supplements (control, n = 32), bisphosphonates (BP, n = 31), teriparatide (TPTD, n = 40) and other strategies (vitamin K2 and strontium; other, n = 4). Median treatment duration and BMD follow-up duration was 27 and 35 months, respectively. Mean lumbar spine BMD measured by dual-energy x-ray absorptiometry was increased at 3-year follow-up in all groups (control, 7.9%; BP, 18.2%; TPTD, 17.0%; other, 8.6%; P < 0.05 for all), with significantly higher BMD change in BP or TPTD compared to control (Bonferroni-corrected P < 0.001 for all). Our findings suggest the potential long-term efficacy of pharmacologic treatments in individuals with PLO with high risk of subsequent fracture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955;268(6861):431–4.

    Article  CAS  PubMed  Google Scholar 

  2. Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol. 1993;39(4):487–90.

    Article  CAS  Google Scholar 

  3. Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int. 2000;11(5):449–54. https://doi.org/10.1007/s001980070113.

    Article  CAS  PubMed  Google Scholar 

  4. Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol. 2018;88(5):652–8. https://doi.org/10.1111/cen.13557.

    Article  CAS  Google Scholar 

  5. Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P. Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int. 2018;29(1):135–42. https://doi.org/10.1007/s00198-017-4239-1.

    Article  CAS  PubMed  Google Scholar 

  6. Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, et al. Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol. 2018;37(11):3141–50. https://doi.org/10.1007/s10067-018-4185-0.

    Article  PubMed  Google Scholar 

  7. Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y. Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int. 2017;28(11):3135–42. https://doi.org/10.1007/s00198-017-4165-2.

    Article  CAS  PubMed  Google Scholar 

  8. Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I. Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int. 2017;28(4):1393–9. https://doi.org/10.1007/s00198-016-3897-8.

    Article  CAS  PubMed  Google Scholar 

  9. O'Sullivan SM, Grey AB, Singh R, Reid IR. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int. 2006;17(7):1008–12. https://doi.org/10.1007/s00198-006-0112-3.

    Article  CAS  PubMed  Google Scholar 

  10. Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA. Case report: teriparatide treatment in a case of severe pregnancy- and lactation-associated osteoporosis. Hormones (Athens, Greece). 2012;11(4):495–500.

    Article  Google Scholar 

  11. Stumpf UC, Kurth AA, Windolf J, Fassbender WJ. Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci. 2007;52:94–7.

    CAS  PubMed  Google Scholar 

  12. Jang JY, Lee JG, Jeong IK, Ahn KJ, Chung HY, Yang HI, et al. A case of post-pregnancy osteoporosis combined with ankylosing spondylitis. Rheumatol Int. 2009;29(11):1359–62. https://doi.org/10.1007/s00296-008-0820-4.

    Article  PubMed  Google Scholar 

  13. Allali F, Guedirra N, Hajjaj-Hassouni N. A case of post-pregnancy osteoporosis-related spinal fractures in association with ankylosing spondylitis. Clin Rheumatol. 2005;24(4):435–6. https://doi.org/10.1007/s10067-004-1074-5.

    Article  PubMed  Google Scholar 

  14. Tran HA, Petrovsky N. Pregnancy-associated osteoporosis with hypercalcaemia. Intern Med J. 2002;32(9–10):481–5.

    Article  CAS  PubMed  Google Scholar 

  15. Rillo OL, Di Stefano CA, Bermudez J, Maldonado Cocco JA. Idiopathic osteoporosis during pregnancy. Clin Rheumatol. 1994;13(2):299–304.

    Article  CAS  PubMed  Google Scholar 

  16. Grizzo FM, da Silva Martins J, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM. Pregnancy and lactation-associated osteoporosis: bone histomorphometric analysis and response to treatment with zoledronic acid. Calcif Tissue Int. 2015;97(4):421–5. https://doi.org/10.1007/s00223-015-0028-z.

    Article  CAS  PubMed  Google Scholar 

  17. Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS. Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J. 2009;9(4):e20–4. https://doi.org/10.1016/j.spinee.2008.06.451.

    Article  PubMed  Google Scholar 

  18. Smith R, Athanasou NA, Ostlere SJ, Vipond SE. Pregnancy-associated osteoporosis. QJM. 1995;88(12):865–78.

    CAS  PubMed  Google Scholar 

  19. Blanch J, Pacifici R, Chines A. Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol. 1994;33(3):269–72.

    Article  CAS  PubMed  Google Scholar 

  20. Zhang M, Chen P, Li B, Du J, Pan T, Chen J. Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature. Medicine (Baltimore). 2017;96(46):e8671. https://doi.org/10.1097/MD.0000000000008671.

    Article  Google Scholar 

  21. Honjo S, Mizunuma H. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis. Am J Obstet Gynecol. 2001;185(1):246–7. https://doi.org/10.1067/mob.2001.113910.

    Article  CAS  PubMed  Google Scholar 

  22. Anai T, Tomiyasu T, Arima K, Miyakawa I. Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res. 1999;25(1):63–7.

    Article  CAS  PubMed  Google Scholar 

  23. Sarikaya S, Ozdolap S, Acikgoz G, Erdem CZ. Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine. 2004;71(1):84–5. https://doi.org/10.1016/j.jbspin.2003.05.003.

    Article  PubMed  Google Scholar 

  24. Vujasinovic-Stupar N, Pejnovic N, Markovic L, Zlatanovic M. Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome. Rheumatol Int. 2012;32(3):819–23. https://doi.org/10.1007/s00296-011-1816-z.

    Article  PubMed  Google Scholar 

  25. Reid IR, Wattie DJ, Evans MC, Budayr AA. Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol. 1992;37(3):298–303.

    Article  CAS  Google Scholar 

  26. Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah I, et al. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol. 2008;35(12):2344–7. https://doi.org/10.3899/jrheum.080634.

    Article  CAS  PubMed  Google Scholar 

  27. Fuleihan Gel H, Salamoun M, Mourad YA, Chehal A, Salem Z, Mahfoud Z, et al. Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab. 2005;90(6):3209–14. https://doi.org/10.1210/jc.2004-1444.

    Article  CAS  Google Scholar 

  28. Minsker DH, Manson JM, Peter CP. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol. 1993;121(2):217–23. https://doi.org/10.1006/taap.1993.1148.

    Article  CAS  PubMed  Google Scholar 

  29. Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44(3):428–30. https://doi.org/10.1016/j.bone.2008.11.001.

    Article  CAS  PubMed  Google Scholar 

  30. Cohen A. Premenopausal osteoporosis. Endocrinol Metab Clin N Am. 2017;46(1):117–33. https://doi.org/10.1016/j.ecl.2016.09.007.

    Article  Google Scholar 

  31. Cohen A, Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, et al. Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab. 2013;98(5):1971–81. https://doi.org/10.1210/jc.2013-1172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab. 2014;99(4):1322–9. https://doi.org/10.1210/jc.2013-4105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab. 2012;30(5):596–601. https://doi.org/10.1007/s00774-011-0334-0.

    Article  CAS  PubMed  Google Scholar 

  34. Polat SB, Evranos B, Aydin C, Cuhaci N, Ersoy R, Cakir B. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature. Gynecol Endocrinol. 2015;31(7):522–5. https://doi.org/10.3109/09513590.2015.1014787.

    Article  PubMed  Google Scholar 

  35. Coskun Benlidayi I, Sarpel T, Guzel R. Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol. 2014;34(8):736. https://doi.org/10.3109/01443615.2014.920800.

    Article  CAS  PubMed  Google Scholar 

  36. Hellmeyer L, Boekhoff J, Hadji P. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol. 2010;26(10):725–8. https://doi.org/10.3109/09513591003649831.

    Article  CAS  PubMed  Google Scholar 

  37. Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol. 2017;56(6):863–6. https://doi.org/10.1016/j.tjog.2017.10.028.

    Article  PubMed  Google Scholar 

  38. Cohen A, Kamanda-Kosseh M, Recker RR, Lappe JM, Dempster DW, Zhou H, et al. Bone density after teriparatide discontinuation in premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab. 2015;100(11):4208–14. https://doi.org/10.1210/jc.2015-2829.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Tsuchie H, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Shimada Y. Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K(2): a report of four patients. Ups J Med Sci. 2012;117(3):336–41. https://doi.org/10.3109/03009734.2012.676573.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea

    Namki Hong & Yumie Rhee

Authors
  1. Namki Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yumie Rhee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yumie Rhee.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

Not applicable.

Informed Consent

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hong, N., Rhee, Y. Comparison of Efficacy of Pharmacologic Treatments in Pregnancy- and Lactation-Associated Osteoporosis. Clinic Rev Bone Miner Metab 17, 86–93 (2019). https://doi.org/10.1007/s12018-019-09262-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-019-09262-2

Keywords

Search

Navigation